search
Back to results

Effects of Training on Central Auditory Function in Multiple Sclerosis

Primary Purpose

Multiple Sclerosis

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Auditory training
MS: Control Activity
Sponsored by
VA Office of Research and Development
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Multiple Sclerosis focused on measuring MS, CAP

Eligibility Criteria

21 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • age 21-65 years;
  • a clinical or laboratory supported diagnosis of "definite" MS;
  • a diagnosis of relapsing-remitting, primary progressive, or secondary progressive MS;
  • a Kurtzke Expanded Disability Status Score (EDSS) of 0 to 7.0, inclusive;
  • no history of a clinical relapse or change in EDSS for three months preceding entry into the study; and
  • a brain MRI scan that shows at least three white-matter lesions on T2-weighted images consistent with MS

Exclusion Criteria:

  • current major disease or disorder other than MS (e.g., cancer, end-stage renal disease, end-stage cardiopulmonary disease, post-traumatic stress disorder, diabetes);
  • other neurological conditions that could interfere with the ability to respond to tests and questionnaires;
  • non-native speaker of English (since test materials are presented in English);
  • pregnant (due to potential negative effects on the fetus during fMRI);
  • more than a mild degree (less than a 40 dB HL four-frequency pure-tone average [PTA]) of hearing loss bilaterally (since the presence of more than a mild degree of peripheral hearing impairment may impact CAP test results);
  • metal implants (due to fMRI constraints); and
  • left-handedness

Sites / Locations

  • VA Portland Health Care System, Portland, OR

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

No Intervention

Active Comparator

Placebo Comparator

Arm Label

Non-MS Control

MS: Auditory Training

MS: Control Activity

Arm Description

Non-MS control group

MS group receiving auditory training

MS group not receiving auditory training, doing control activity

Outcomes

Primary Outcome Measures

Electrophysiological Auditory Test
auditory P300 amplitude in response to "rare" 1000 Hz tones

Secondary Outcome Measures

Neural Magnetic Resonance Imaging (MRI)
Gray matter volume
SCAN-A: Competing Words Test
The SCAN-A: Competing Words Test assesses participants' auditory processing abilities via a dichotic listening task. Lists of word pairs are presented separately to each ear, and participants repeat the words they hear. Possible range of scores = 0-20, with higher scores indicating better performance.

Full Information

First Posted
November 30, 2009
Last Updated
September 10, 2018
Sponsor
VA Office of Research and Development
Collaborators
Oregon Health and Science University
search

1. Study Identification

Unique Protocol Identification Number
NCT01023074
Brief Title
Effects of Training on Central Auditory Function in Multiple Sclerosis
Official Title
Effects of Training on Central Auditory Function in Multiple Sclerosis
Study Type
Interventional

2. Study Status

Record Verification Date
September 2018
Overall Recruitment Status
Completed
Study Start Date
October 2007 (undefined)
Primary Completion Date
June 2011 (Actual)
Study Completion Date
June 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
VA Office of Research and Development
Collaborators
Oregon Health and Science University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to characterize the central auditory processing (CAP) deficits that result from multiple sclerosis (MS).
Detailed Description
Five general types of evaluations will be employed over multiple study sessions at the National Center for Rehabilitative Auditory Research (NCRAR). First, a neurologist will review the subject's medical history and perform a neurologic exam to confirm MS diagnosis. Second, peripheral auditory function will be evaluated using a standard set of routine audiometric tests. Additionally, subjects will complete a case history and series of hearing handicap inventories. Third, a battery of behavioral procedures will be used to characterize central auditory processing. Fourth, auditory evoked potential studies will be performed. Emphasis here will be upon evoked potentials whose putative neural generators lie within the central auditory nervous system. Fifth, subjects will receive magnetic resonance imaging (MRI) evaluation to determine sites and amount of neural degeneration.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Multiple Sclerosis
Keywords
MS, CAP

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
52 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Non-MS Control
Arm Type
No Intervention
Arm Description
Non-MS control group
Arm Title
MS: Auditory Training
Arm Type
Active Comparator
Arm Description
MS group receiving auditory training
Arm Title
MS: Control Activity
Arm Type
Placebo Comparator
Arm Description
MS group not receiving auditory training, doing control activity
Intervention Type
Behavioral
Intervention Name(s)
Auditory training
Intervention Description
the study was originally set up so that half of the MS subjects would received auditory training. This intervention has since been discontinued.
Intervention Type
Other
Intervention Name(s)
MS: Control Activity
Intervention Description
MS group not receiving auditory training, doing control activity
Primary Outcome Measure Information:
Title
Electrophysiological Auditory Test
Description
auditory P300 amplitude in response to "rare" 1000 Hz tones
Time Frame
Recordings were conducted during one session
Secondary Outcome Measure Information:
Title
Neural Magnetic Resonance Imaging (MRI)
Description
Gray matter volume
Time Frame
Results were recorded during one scanning session
Title
SCAN-A: Competing Words Test
Description
The SCAN-A: Competing Words Test assesses participants' auditory processing abilities via a dichotic listening task. Lists of word pairs are presented separately to each ear, and participants repeat the words they hear. Possible range of scores = 0-20, with higher scores indicating better performance.
Time Frame
Test administered during one session

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: age 21-65 years; a clinical or laboratory supported diagnosis of "definite" MS; a diagnosis of relapsing-remitting, primary progressive, or secondary progressive MS; a Kurtzke Expanded Disability Status Score (EDSS) of 0 to 7.0, inclusive; no history of a clinical relapse or change in EDSS for three months preceding entry into the study; and a brain MRI scan that shows at least three white-matter lesions on T2-weighted images consistent with MS Exclusion Criteria: current major disease or disorder other than MS (e.g., cancer, end-stage renal disease, end-stage cardiopulmonary disease, post-traumatic stress disorder, diabetes); other neurological conditions that could interfere with the ability to respond to tests and questionnaires; non-native speaker of English (since test materials are presented in English); pregnant (due to potential negative effects on the fetus during fMRI); more than a mild degree (less than a 40 dB HL four-frequency pure-tone average [PTA]) of hearing loss bilaterally (since the presence of more than a mild degree of peripheral hearing impairment may impact CAP test results); metal implants (due to fMRI constraints); and left-handedness
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dennis N. Bourdette, MD
Organizational Affiliation
VA Portland Health Care System, Portland, OR
Official's Role
Principal Investigator
Facility Information:
Facility Name
VA Portland Health Care System, Portland, OR
City
Portland
State/Province
Oregon
ZIP/Postal Code
97239
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Effects of Training on Central Auditory Function in Multiple Sclerosis

We'll reach out to this number within 24 hrs